Status:
COMPLETED
An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers
Lead Sponsor:
Brooke Army Medical Center
Collaborating Sponsors:
GlaxoSmithKline
Becton, Dickinson and Company
Conditions:
Community-Acquired MRSA Infections
Abscesses
Eligibility:
All Genders
17-60 years
Phase:
NA
Brief Summary
The main purpose of this study is to determine if applying mupirocin into soldiers noses who are colonized with methicillin-resistant Staphylococcus aureus (MRSA) will reduce infections in them and th...
Detailed Description
Community-acquired MRSA infections are increasingly common in the community and in particular among certain groups of which soldiers are one. Many researchers and clinicians have postulated that one m...
Eligibility Criteria
Inclusion
- Soldiers enrolled into the combat medic course at Ft. Sam Houston, TX.
- \-
Exclusion
- Allergy to mupirocin.
- \-
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT00289588
Start Date
January 1 2005
End Date
December 1 2005
Last Update
February 16 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brooke Army Medical Center
Fort Sam Houston, Texas, United States, 78234